Trials / Unknown
UnknownNCT03329118
Drug-drug Interaction Between Simvastatin and SHR3824
Drug Interaction Study of Henagliflozin and Simvastatin in Healthy Volunteers
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
the purpose of thr study is to investigate the potential interation between multiple oral doses of SHR3824 and single oral dose of Simvastatin in healthy adult volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR3824, Simvastatin | two 20mg tablets of simvastatin once daily on Day 1 followed by one 10mg tablet of SHR3824 once daily on Day 4,5,6,7,followed by two 20mg tablets of simvastatin and one 10mg tablet of SHR3824 on Day 8. |
Timeline
- Start date
- 2017-11-24
- Primary completion
- 2017-12-04
- Completion
- 2017-12-08
- First posted
- 2017-11-01
- Last updated
- 2017-11-09
Source: ClinicalTrials.gov record NCT03329118. Inclusion in this directory is not an endorsement.